Spersadex comp., collyre en solution
7680305140255
CH-30514
Augentropfen
Associated product:
SPERSADEX comp. gtt opht fl 5 ml
1 / 3
google
Article details
- Package size
- 5
- Selling units
- 5
- Measure
- ml
- Galenic form
- Augentropfen
- Galenic group
- Augenmittel
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
chloramphenicolum
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
dexamethasoni natrii phosphas
|
1.0 MG | Substance | Wirkstoff (Principe actif) |
|
benzalkonii chloridum
|
100.0 UG | Substance | HBESI |
|
dinatrii edetas
|
- | Substance | HNIDK |
|
macrogolum 400
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
macrogolglyceroli ricinoleas
|
30.0 MG | Substance | HBESI |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
phosphas
|
200.0 UG | Substance | HBESI |
Authorization holder
THEA Pharma S.A.
8200 Schaffhausen
Authorization information
- Swissmedic authorization number
- 30514
- Drug name
- Spersadex comp., collyre en solution
- Galenic form
- AUL
- ATC Code
- S01CA01
- Authorization status
- Revoked/Withdrawn
- Dispensing category
- A
- First authorization
- 19/05/1964
- Authorization expiration date
- 17/07/2026
- IT Number
- 11.06.1.
- Domain
- Human medicine
Package details
- Description (FR)
- SPERSADEX comp. gtt opht fl 5 ml
- Description (DE)
- SPERSADEX comp. Gtt Opht Fl 5 ml
- Market launch
- 20/01/2006
- Market withdrawal
- 17/07/2026
- Narcotic (BTM)
- No
Other package sizes (1)
None
5 ML
GTIN: None